ATE339962T1 - Zubereitungen zur behandlung von lupus - Google Patents

Zubereitungen zur behandlung von lupus

Info

Publication number
ATE339962T1
ATE339962T1 AT02804752T AT02804752T ATE339962T1 AT E339962 T1 ATE339962 T1 AT E339962T1 AT 02804752 T AT02804752 T AT 02804752T AT 02804752 T AT02804752 T AT 02804752T AT E339962 T1 ATE339962 T1 AT E339962T1
Authority
AT
Austria
Prior art keywords
bromelain
quercetin
vitamin
composition
myricetin
Prior art date
Application number
AT02804752T
Other languages
English (en)
Inventor
Randy H Ziegler
Original Assignee
Randy H Ziegler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Randy H Ziegler filed Critical Randy H Ziegler
Application granted granted Critical
Publication of ATE339962T1 publication Critical patent/ATE339962T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT02804752T 2001-12-07 2002-12-09 Zubereitungen zur behandlung von lupus ATE339962T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33919901P 2001-12-07 2001-12-07

Publications (1)

Publication Number Publication Date
ATE339962T1 true ATE339962T1 (de) 2006-10-15

Family

ID=23327940

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02804752T ATE339962T1 (de) 2001-12-07 2002-12-09 Zubereitungen zur behandlung von lupus

Country Status (8)

Country Link
US (1) US20040248821A1 (de)
EP (1) EP1450835B1 (de)
CN (1) CN1606448A (de)
AT (1) ATE339962T1 (de)
AU (1) AU2002366645A1 (de)
BR (1) BR0207061A (de)
DE (1) DE60214881T2 (de)
WO (1) WO2003049725A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10321725A1 (de) * 2003-05-14 2004-12-02 Mucos Pharma Gmbh & Co Enzymhaltige Zusammensetzungen, daraus hergestellte diätetische Lebensmittel und Arzneimittel und ihre Verwendung für medizinische Zwecke
CN1327834C (zh) * 2004-10-12 2007-07-25 中国药科大学 防治皮肤瘙痒症的药物组合物
WO2007084857A2 (en) * 2006-01-13 2007-07-26 President And Fellows Of Harvard College Methods and compositions for treating cell proliferative disorders
DK2231173T3 (da) * 2007-12-12 2014-07-21 Dacy Tech Pty Ltd Nutraceutisk præparat og fremgangsmåder til anvendelse
US10376550B2 (en) 2007-12-12 2019-08-13 Dacy Tech Pty Ltd. Nutraceutical composition and methods of use
EP2240190A4 (de) * 2007-12-12 2011-07-06 Dacy Tech Pty Ltd Nutrazeutische zusammensetzung und anwendungsverfahren
NZ591025A (en) * 2008-08-21 2013-01-25 Alvine Pharmaceuticals Inc Formulation for oral administration of proteins
WO2010075611A1 (en) * 2009-01-05 2010-07-08 Bio - Enhancements Pty Ltd Composition comprising proanthocyanidin, proteolytic enzyme and aloe vera/agave species substance

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19957318A1 (de) * 1999-11-29 2001-06-21 Mucos Pharma Gmbh & Co Beeinflussung von TGF-Beta durch Proteolytische Enzyme
WO2002007768A1 (en) * 2000-07-20 2002-01-31 Pitman Bradford D Dietary supplement compositions

Also Published As

Publication number Publication date
EP1450835A2 (de) 2004-09-01
AU2002366645A8 (en) 2003-06-23
EP1450835B1 (de) 2006-09-20
BR0207061A (pt) 2004-02-17
US20040248821A1 (en) 2004-12-09
WO2003049725A2 (en) 2003-06-19
AU2002366645A1 (en) 2003-06-23
DE60214881D1 (de) 2006-11-02
CN1606448A (zh) 2005-04-13
WO2003049725A3 (en) 2003-10-02
DE60214881T2 (de) 2007-05-03

Similar Documents

Publication Publication Date Title
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
BR0109912A (pt) Novas combinações antelmìnticas
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
DK0915898T3 (da) Krystalform I af clarithromycin
BR0111210A (pt) Composição para o tratamento e/ou prevenção de osteoporose e/ou doenças de juntas inflamatórias
NO20025450D0 (no) Ny farmasöytisk sammensetning
FR2757520B1 (fr) Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent
ATE334978T1 (de) Zusammensetzungen und therapeutische anwendungen von isoflavonen und deren analoga
BR0209129A (pt) Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos
TR200103634T2 (tr) Bitkilerde flavonoidlerin ve fenolik maddelerin miktarını arttırma yöntemi.
WO2002091858A8 (en) Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods
BR0113463A (pt) Composição farmacêutica para o tratamento e/ou prevenção de infecções clamidiais, composição pró-saúde e seu uso
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
DE60214881D1 (de) Zubereitungen zur behandlung von lupus
BR0213449A (pt) Comprimido mastigável contendo lisina
TR200100637T2 (tr) Yeni doğal ürün türevleri
BR0107701A (pt) Produtos alimentìcios e processos
MY135460A (en) Method of stimulating hair growth using benzopyrans
SE0004101D0 (sv) New use
BRPI0418854A (pt) composições herbáceas
NO970178D0 (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties